跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NUVARING 0,120 mg/0,015 mg CADA 24 HORAS, SISTEMA DE LIBERACION VAGINAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
NUVARING 0,120 mg/0,015 mg CADA 24 HORAS, SISTEMA DE LIBERACION VAGINAL
Approved
STANDARD
NUVARING 0,120 mg/0,015 mg CADA 24 HORAS, SISTEMA DE LIBERACION VAGINAL
Organon Portugal Sociedade Unipessoal Lda.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 15, 2020
Approval ID
b615d7f5bfbd66d4
Company
Organon Portugal Sociedade Unipessoal Lda.
Type
Standard
Approval Details
Approval Id
b615d7f5bfbd66d4
Drug Cima Aemps Name
NUVARING 0,120 mg/0,015 mg CADA 24 HORAS, SISTEMA DE LIBERACION VAGINAL
Register Number
5717756
Holder Company Name
Organon Portugal Sociedade Unipessoal Lda.
Marketing Company Name
Melyfarma S.L.
Authorization Date
2020-09-15
Dosage Form
SISTEMA DE LIBERACIÓN VAGINAL
Dose
11,7 mg/ 2,7 mg
Route Of Administration
VÍA VAGINAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Organon Portugal Sociedade Unipessoal Lda.
Active Ingredients
ETONOGESTREL
11,7 mg
ETINILESTRADIOL
2,7 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 15, 2020
Approval ID
b615d7f5bfbd66d4
Type
Standard
Back to CIMA-AEMPS Approvals